Last update:

Coronavirus (COVID-19)

AI-designed universal vaccine clears first human trial, targets future coronavirus threats with needle-free delivery

The first human clinical trial of a universal Sarbeco coronavirus vaccine, developed by the University of Cambridge and spin-out DIOSynVax (DVX) Ltd, has shown that the vaccine is safe and has no significant side effects.

COVID-19 vaccine boosters may help protect against future animal coronaviruses, research suggests

COVID-19 vaccine boosters not only protect against SARS-CoV-2—the virus behind the most recent pandemic—but may also help protect against some future coronaviruses that risk spreading from animals to humans, Cambridge researchers ...

COVID-19 outbreak

Coronavirus disease 2019 (COVID-19) is the infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

A pneumonia of unknown cause detected in Wuhan, China was first reported to the World Health Organization Country Office in China on 31 December 2019 and recognised as a pandemic on 11 March 2020.

Reported illnesses have ranged from mild symptoms to severe illness and death for confirmed COVID-19 cases.

More information: WHO, CDC, global cases.

Follow us on Google News for the latest updates on the coronavirus.

Pandemic treaty talks roll on into September

Countries failed to find a breakthrough after a seventh round of talks aimed at finalizing the missing piece of a pandemic treaty, the World Health Organization said Monday.

COVID-19 booster strategies provide lasting immunity

Smaller doses of COVID-19 booster vaccines can provide long-lasting immunity, helping reduce costs and improve access to vaccination, according to new research. The findings could also inform vaccine dosing and options during ...